阿兹海默症药物试制失败（朗读版）｜E1209

Eli Lilly said that a clinical trial for a new drug to slow the onset of Alzheimer’s had failed. The drug, solanezumab, was tested on patients with mild cases of Alzheimer’s, who showed only a slight improvement after 18 months of treatment. The experiment had been closely watched by medical researchers and hopes were high that solanezumab would be the first drug approved to treat the disease.

Clinical trial: 临床试验
Onset：开始
Alzheimer‘s： 老年痴呆症

英语学新闻，睁眼看世界。
每周一、三、五更新，为您提供最新鲜的英语新闻讲解；
每周二、四，夏老师新浪微博内会放出复习新闻讲解。
欢迎搜索《夏说英文-暴虐跟读集训营 【单集体验版】》收听体验暴虐朗读版。
欢迎搜索 《夏说英文-暴虐跟读集训营【全年订阅版】》购买一年的暴虐朗读版，享受6折优惠。

想了解更多关于我们的信息，
请关注
新浪微博：教书匠小夏
微信公众号：教书匠小夏
推荐关注微信公众号收听美音版：我是Wanderer
添加微信：treeism10 咨询友邻优课会员收费课程。